Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Design of a prospective observational study on the effectiveness and real-world usage of recombinant factor VIII Fc (rFVIIIFc) compared with conventional products in haemophilia A: the A-SURE study.

Oldenburg J, Hay CRM, Jiménez-Yuste V, Peyvandi F, Schved JF, Szamosi J, Winding B, Lethagen S.

BMJ Open. 2019 May 30;9(5):e028012. doi: 10.1136/bmjopen-2018-028012.

2.

Kinetics of the coagulation cascade including the contact activation system: sensitivity analysis and model reduction.

Méndez Rojano R, Mendez S, Lucor D, Ranc A, Giansily-Blaizot M, Schved JF, Nicoud F.

Biomech Model Mechanobiol. 2019 Aug;18(4):1139-1153. doi: 10.1007/s10237-019-01134-4. Epub 2019 Mar 21.

PMID:
30900051
3.

Eptacog beta: a novel recombinant human factor VIIa for the treatment of hemophilia A and B with inhibitors.

Biron-Andreani C, Schved JF.

Expert Rev Hematol. 2019 Jan;12(1):21-28. doi: 10.1080/17474086.2019.1560259. Epub 2019 Jan 28.

PMID:
30577721
4.

Inherited or acquired modifiers of iron status may dramatically affect the phenotype in dehydrated hereditary stomatocytosis.

Orvain C, Da Costa L, Van Wijk R, Pissard S, Picard V, Mansour-Hendili L, Cunat S, Giansily-Blaizot M, Cartron G, Schved JF, Aguilar-Martinez P.

Eur J Haematol. 2018 Oct;101(4):566-569. doi: 10.1111/ejh.13135. Epub 2018 Aug 31.

PMID:
29969830
5.

[Direct oral anticoagulants (DOACS): A necessary focus].

Laroche JP, Becker F, Schved JF.

J Med Vasc. 2018 May;43(3):198-205. doi: 10.1016/j.jdmv.2018.02.005. Epub 2018 Mar 28. Review. French.

PMID:
29754730
6.

[Time in therapeutic range (TTR) and follow-up of patients on vitamin K antagonist: A cohort analysis].

Valdelièvre E, Quéré I, Caré B, Laroche JP, Schved JF.

J Med Vasc. 2018 May;43(3):155-162. doi: 10.1016/j.jdmv.2018.02.001. Epub 2018 Mar 17. French.

PMID:
29754725
7.

Management of bleeding and emergency invasive procedures in patients on dabigatran: Updated guidelines from the French Working Group on Perioperative Haemostasis (GIHP) - September 2016.

Albaladejo P, Pernod G, Godier A, de Maistre E, Rosencher N, Mas JL, Fontana P, Samama CM, Steib A, Schlumberger S, Marret E, Roullet S, Susen S, Madi-Jebara S, Nguyen P, Schved JF, Bonhomme F, Sié P; members of the French Working Group on Perioperative Haemostasis.

Anaesth Crit Care Pain Med. 2018 Aug;37(4):391-399. doi: 10.1016/j.accpm.2018.04.009. Epub 2018 May 2. Review.

8.

After the SIPPET study: Position paper of the CoMETH, the French society of haemophilia.

Lebreton A, Castet S, Falaise C, Rugeri L, Schved JF, Wibaut B.

Haemophilia. 2018 Mar;24(2):e55-e57. doi: 10.1111/hae.13400. Epub 2018 Jan 9. No abstract available.

PMID:
29316084
9.

Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date.

Giansily-Blaizot M, Schved JF.

Ther Adv Hematol. 2017 Dec;8(12):345-352. doi: 10.1177/2040620717737701. Epub 2017 Nov 3. Review.

10.

PERSEPT 1: a phase 3 trial of activated eptacog beta for on-demand treatment of haemophilia inhibitor-related bleeding.

Wang M, Lawrence JB, Quon DV, Ducore J, Simpson ML, Boggio LN, Mitchell IS, Yuan G, Alexander WA, Schved JF.

Haemophilia. 2017 Nov;23(6):832-843. doi: 10.1111/hae.13301. Epub 2017 Aug 3.

PMID:
28776894
11.

Iatrogenic acquired factor V inhibitors: A case report and review of the French pharmacovigilance database.

Theron A, Burcheri S, Vacheret F, Hillaire-Buys D, Sauguet P, Schved JF, Faillie JL, Biron-Andreani C.

Thromb Res. 2017 Sep;157:154-156. doi: 10.1016/j.thromres.2017.06.007. Epub 2017 Jun 8. Review. No abstract available.

PMID:
28755628
12.

Chemical vs. radioactive synoviorthesis for treatment of chronic haemophilic synovitis: Syrian experience.

Ali T, Abou Fakher FH, Schved JF.

Haemophilia. 2016 Nov;22(6):e573-e575. doi: 10.1111/hae.13129. No abstract available.

PMID:
27868370
13.

[Vitamin K antagonist, direct oral anticoagulants: Where is the truth?]

Laroche JP, Schved JF.

J Mal Vasc. 2016 Dec;41(6):383-388. doi: 10.1016/j.jmv.2016.10.002. Epub 2016 Nov 3. French.

PMID:
27817997
14.

European retrospective study of real-life haemophilia treatment.

Berntorp E, Dolan G, Hay C, Linari S, Santagostino E, Tosetto A, Castaman G, Álvarez-Román MT, Parra Lopez R, Oldenburg J, Albert T, Scholz U, Holmström M, Schved JF, Trossaërt M, Hermans C, Boban A, Ludlam C, Lethagen S.

Haemophilia. 2017 Jan;23(1):105-114. doi: 10.1111/hae.13111. Epub 2016 Oct 20.

PMID:
27761962
15.

Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015.

Albaladejo P, Bonhomme F, Blais N, Collet JP, Faraoni D, Fontana P, Godier A, Llau J, Longrois D, Marret E, Mismetti P, Rosencher N, Roullet S, Samama CM, Schved JF, Sié P, Steib A, Susen S; French Working Group on Perioperative Hemostasis (GIHP).

Anaesth Crit Care Pain Med. 2017 Feb;36(1):73-76. doi: 10.1016/j.accpm.2016.09.002. Epub 2016 Sep 20.

16.

Circulating FVIII-specific IgG, IgA and IgM memory B cells from haemophilia A patients.

Diaz I, Bolloré K, Tuaillon E, Lapalud P, Giansily-Blaizot M, Vendrell JP, Schved JF, Lavigne-Lissalde G.

Haemophilia. 2016 Sep;22(5):799-805. doi: 10.1111/hae.12958. Epub 2016 Jul 21.

PMID:
27439547
17.

Rare coagulation disorders: fibrinogen, factor VII and factor XIII.

de Moerloose P, Schved JF, Nugent D.

Haemophilia. 2016 Jul;22 Suppl 5:61-5. doi: 10.1111/hae.12965. Review.

PMID:
27405678
18.

Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.

Napolitano M, Di Minno MN, Batorova A, Dolce A, Giansily-Blaizot M, Ingerslev J, Schved JF, Auerswald G, Kenet G, Karimi M, Shamsi T, Ruiz de Sáez A, Dolatkhah R, Chuansumrit A, Bertrand MA, Mariani G.

Haemophilia. 2016 Sep;22(5):752-9. doi: 10.1111/hae.12978. Epub 2016 Jun 24.

PMID:
27338009
19.

Influence of surgical bleeding on the relationship between admission coagulopathy and risk of massive transfusion: lesson from 704 severe trauma patients.

Charbit J, Lakhal K, Deras P, Dehon A, Latry P, Boissier E, Schved JF, Capdevila X.

Vox Sang. 2016 Aug;111(2):151-60. doi: 10.1111/vox.12401. Epub 2016 May 30.

PMID:
27240119
20.

Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology.

Pfeiffer C, Mathieu-Dupas E, Logghe P, Lissalde-Lavigne G, Balicchi J, Caliskan U, Valentin T, Laune D, Molina F, Schved JF, Giansily-Blaizot M.

Thromb Res. 2016 May;141:22-7. doi: 10.1016/j.thromres.2016.02.021. Epub 2016 Feb 23.

PMID:
26962982
21.

The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.

Funakoshi N, Chaze I, Alary AS, Tachon G, Cunat S, Giansily-Blaizot M, Bismuth M, Larrey D, Pageaux GP, Schved JF, Donnadieu-Rigole H, Blanc P, Aguilar-Martinez P.

Liver Int. 2016 May;36(5):746-54. doi: 10.1111/liv.12984. Epub 2015 Nov 7.

PMID:
26474245
22.

[Congenital haemorrhagic diseases].

Schved JF.

Rev Prat. 2015 May;65(5):613-7. Review. French.

PMID:
26165091
23.

[Hemorrhagic congenital diseases: What can be the future of plasma-derived products against recombinants?].

Schved JF.

Transfus Clin Biol. 2015 Aug;22(3):85-9. doi: 10.1016/j.tracli.2015.03.006. Epub 2015 Apr 29. French.

PMID:
25933512
24.

Anti-A2 and anti-A1 domain antibodies are potential predictors of immune tolerance induction outcome in children with hemophilia A.

Lapalud P, Rothschild C, Mathieu-Dupas E, Balicchi J, Gruel Y, Laune D, Molina F, Schved JF, Granier C, Lavigne-Lissalde G.

J Thromb Haemost. 2015 Apr;13(4):540-7. doi: 10.1111/jth.12846. Epub 2015 Feb 27.

25.

Short-term and mid-term outcome of total ankle replacement in haemophilic patients.

Asencio JG, Leonardi C, Biron-Andreani C, Schved JF.

Foot Ankle Surg. 2014 Dec;20(4):285-92. doi: 10.1016/j.fas.2014.08.004. Epub 2014 Aug 19.

PMID:
25457668
26.

Computer-predicted peptides that mimic discontinuous epitopes on the A2 domain of factor VIII.

Lebreton A, Simon N, Moreau V, Demolombe V, Cayzac C, Nguyen C, Schved JF, Granier C, Lavigne-Lissalde G.

Haemophilia. 2015 May;21(3):e193-201. doi: 10.1111/hae.12575. Epub 2014 Nov 24.

PMID:
25422151
27.

DNA repair in diffuse large B-cell lymphoma: a molecular portrait.

Bret C, Klein B, Cartron G, Schved JF, Constantinou A, Pasero P, Moreaux J.

Br J Haematol. 2015 Apr;169(2):296-9. doi: 10.1111/bjh.13206. Epub 2014 Nov 5. No abstract available.

PMID:
25369781
28.

Are low-density lipoprotein receptor-related protein 1 or non-neutralizing antibodies predictors of FVIII in vivo recovery in haemophilia A patients?

Clere AS, Diaz I, Lebreton A, Lavigne-Lissalde G, Schved JF, Biron-Andreani C.

Haemophilia. 2014 Nov;20(6):e406-8. doi: 10.1111/hae.12508. Epub 2014 Oct 14. No abstract available.

PMID:
25311419
29.

[Carriers of haemophilia: Experience of a French university hospital].

Sauguet P, Aguilar-Martinez P, Boulot P, Escudié JB, Schved JF, Biron-Andréani C.

J Gynecol Obstet Biol Reprod (Paris). 2015 Jun;44(6):565-76. doi: 10.1016/j.jgyn.2014.08.009. Epub 2014 Sep 26. French.

30.

Early coagulopathy at hospital admission predicts initial or delayed fibrinogen deficit in severe trauma patients.

Deras P, Villiet M, Manzanera J, Latry P, Schved JF, Capdevila X, Charbit J.

J Trauma Acute Care Surg. 2014 Sep;77(3):433-40. doi: 10.1097/TA.0000000000000314.

PMID:
25159247
31.

Coagulation factor VII variants resistant to inhibitory antibodies.

Branchini A, Baroni M, Pfeiffer C, Batorova A, Giansily-Blaizot M, Schved JF, Mariani G, Bernardi F, Pinotti M.

Thromb Haemost. 2014 Nov;112(5):972-80. doi: 10.1160/TH14-03-0198. Epub 2014 Aug 7.

PMID:
25104096
32.

[Deep venous thrombosis complications during infections in pediatric patients: analysis of a series of 24 cases].

Nou M, Rodière M, Schved JF, Laroche JP, Quéré I, Dauzat M, Jeziorski E.

Arch Pediatr. 2014 Jul;21(7):697-704. doi: 10.1016/j.arcped.2014.04.031. Epub 2014 Jun 14. French.

PMID:
24938919
33.

A Haut-Doubs FVII variant depending on species-derived-thromboplastin reagent (F7:p.Arg337His).

Mourey G, Tachon G, Pellequer JL, Zawadzki C, Trossaërt M, Bertrand MA, Schved JF, Giansily-Blaizot M.

Haemophilia. 2014 Jul;20(4):e347-9. doi: 10.1111/hae.12455. Epub 2014 May 8. No abstract available.

PMID:
24805822
34.

Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect.

Morfini M, Batorova A, Mariani G, Auerswald G, Bernardi F, Di Minno G, Dolce A, Fede C, Giansily-Blaizot M, Ingerslev J, Martinowitz U, Napolitano M, Pinotti M, Schved JF; International FVII [IF7] and Seven Treatment Evaluation Registry [STER] Study Groups.

Thromb Haemost. 2014 Aug;112(2):424-5. doi: 10.1160/TH13-12-1045. Epub 2014 Apr 24. No abstract available.

PMID:
24763923
35.

[Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors. Proposals of the Working Group on Perioperative Haemostasis (GIHP) - March 2013].

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P.

Ann Fr Anesth Reanim. 2013 Oct;32(10):691-700. doi: 10.1016/j.annfar.2013.04.016. Epub 2013 Aug 30. Review. French. Erratum in: Ann Fr Anesth Reanim. 2014 Mar;33(3):198-9.

PMID:
23993157
36.

Cancer detection and management in patients with haemophilia: a retrospective European multicentre study.

Biron-Andreani C, de Moerloose P, D'oiron R, Chambost H, Schved JF, Hermans C.

Haemophilia. 2014 Jan;20(1):78-82. doi: 10.1111/hae.12250. Epub 2013 Aug 6.

PMID:
23919383
37.

A new high affinity variant Hb Aurillac (β141Leu→Val).

Boursier G, Trouillier S, Blaizot MG, Igual H, Schved JF, Martinez PA.

Hemoglobin. 2013;37(6):584-8. doi: 10.3109/03630269.2013.811595. Epub 2013 Jul 17.

PMID:
23859762
38.

Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP) - March 2013.

Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, Blais N, Fontana P, Cohen A, Llau JV, Rosencher N, Schved JF, de Maistre E, Samama MM, Mismetti P, Sié P; Working Group on Perioperative Haemostasis.

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):382-93. doi: 10.1016/j.acvd.2013.04.009. Epub 2013 Jun 25.

39.

Management of cardiovascular disease in haemophilia.

Cayla G, Morange PE, Chambost H, Schved JF.

Thromb Res. 2013 Jul;132(1):8-14. doi: 10.1016/j.thromres.2013.05.007. Epub 2013 Jun 6. Review.

PMID:
23746627
40.

Genotype and phenotype relationships in 10 Pakistani unrelated patients with inherited factor VII deficiency.

Borhany M, Boijout H, Pellequer JL, Shamsi T, Moulis G, Aguilar-Martinez P, Schved JF, Giansily-Blaizot M.

Haemophilia. 2013 Nov;19(6):893-7. doi: 10.1111/hae.12186. Epub 2013 Jun 4.

PMID:
23731332
41.

Pre-interventional haemostatic assessment: Guidelines from the French Society of Anaesthesia and Intensive Care.

Bonhomme F, Ajzenberg N, Schved JF, Molliex S, Samama CM; French Anaesthetic and Intensive Care Committee on Evaluation of Routine Preoperative Testing; French Society of Anaesthesia and Intensive Care.

Eur J Anaesthesiol. 2013 Apr;30(4):142-62. doi: 10.1097/EJA.0b013e32835f66cd.

PMID:
23435255
42.

[Rare bleeding disorders and invasive procedures].

Bonhomme F, Schved JF, Giansily-Blaizot M, Samama CM, de Moerloose P.

Ann Fr Anesth Reanim. 2013 Mar;32(3):198-205. doi: 10.1016/j.annfar.2013.01.019. Epub 2013 Feb 17. Review. French.

PMID:
23422342
43.

Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).

Napolitano M, Giansily-Blaizot M, Dolce A, Schved JF, Auerswald G, Ingerslev J, Bjerre J, Altisent C, Charoenkwan P, Michaels L, Chuansumrit A, Di Minno G, Caliskan U, Mariani G.

Haematologica. 2013 Apr;98(4):538-44. doi: 10.3324/haematol.2012.074039. Epub 2013 Feb 12.

44.

Homozygous mutation of the 5'UTR region of the L-Ferritin gene in the hereditary hyperferritinemia cataract syndrome and its impact on the phenotype.

Giansily-Blaizot M, Cunat S, Moulis G, Schved JF, Aguilar-Martinez P.

Haematologica. 2013 Apr;98(4):e42-3. doi: 10.3324/haematol.2012.077198. Epub 2013 Jan 8. No abstract available.

45.

Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.

Mariani G, Napolitano M, Dolce A, Pérez Garrido R, Batorova A, Karimi M, Platokouki H, Auerswald G, Bertrand AM, Di Minno G, Schved JF, Bjerre J, Ingerslev J, Sørensen B, Ruiz-Saez A; Seven Treatment Evaluation Registry; International Factor VII Deficiency Study Group.

Thromb Haemost. 2013 Feb;109(2):238-47. doi: 10.1160/TH12-07-0476. Epub 2012 Dec 13.

PMID:
23238632
46.

Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?

Giansily-Blaizot M, Marty S, Chen SW, Pellequer JL, Schved JF.

Thromb Res. 2012 Oct;130 Suppl 1:S47-9. doi: 10.1016/j.thromres.2012.08.273. Review.

PMID:
23026661
47.

The IgG autoimmune response in postpartum acquired hemophilia A targets mainly the A1a1 domain of FVIII.

Lapalud P, Ali T, Cayzac C, Mathieu-Dupas E, Levesque H, Pfeiffer C, Balicchi J, Gruel Y, Borg JY, Schved JF, Granier C, Lavigne-Lissalde G.

J Thromb Haemost. 2012 Sep;10(9):1814-22. doi: 10.1111/j.1538-7836.2012.04850.x.

48.

Registry of hemophilia and other bleeding disorders in Syria.

Ali T, Schved JF.

Haemophilia. 2012 Nov;18(6):851-4. doi: 10.1111/j.1365-2516.2012.02862.x. Epub 2012 Jun 4.

PMID:
22672010
49.

Antiplatelet drug response status does not predict recurrent ischemic events in stable cardiovascular patients: results of the Antiplatelet Drug Resistances and Ischemic Events study.

Reny JL, Berdagué P, Poncet A, Barazer I, Nolli S, Fabbro-Peray P, Schved JF, Bounameaux H, Mach F, de Moerloose P, Fontana P; Antiplatelet Drug Resistances and Ischemic Events (ADRIE) Study Group.

Circulation. 2012 Jun 26;125(25):3201-10. doi: 10.1161/CIRCULATIONAHA.111.085464. Epub 2012 May 21.

PMID:
22615340
50.

Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.

Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, Pergantou H, Platokouki H, Giangrande P, Peerlinck K, Celkan T, Ozdemir N, Bidlingmaier C, Ingerslev J, Giansily-Blaizot M, Schved JF, Gilmore R, Gadisseur A, Benedik-Dolničar M, Kitanovski L, Mikovic D, Musallam KM, Rosendaal FR; European Network of Rare Bleeding Disorders Group.

J Thromb Haemost. 2012 Apr;10(4):615-21. doi: 10.1111/j.1538-7836.2012.04653.x.

Supplemental Content

Loading ...
Support Center